{"id":"https://openalex.org/A5117230793","orcid":"https://orcid.org/0009-0005-1424-7295","observed_orcids":["https://orcid.org/0009-0005-1424-7295"],"display_name":"Matthew Bonderud","raw_author_names":["Matthew Bonderud"],"full_name":"Matthew Bonderud","works_count":22,"cited_by_count":1,"summary_stats":{"2yr_mean_citedness":0.045454545454545456,"h_index":1,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5117230793","orcid":"https://orcid.org/0009-0005-1424-7295","observed_orcids":["https://orcid.org/0009-0005-1424-7295"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210098574","ror":"https://ror.org/016aygb24","display_name":"Zymeworks (Canada)","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]},"years":[2026,2025]}],"last_known_institutions":[{"id":"https://openalex.org/I4210098574","ror":"https://ror.org/016aygb24","display_name":"Zymeworks (Canada)","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","count":16,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","count":15,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","count":9,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","count":7,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","count":6,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","value":0.0001707,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","value":0.0001566,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","value":0.0001181,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","value":0.0001014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","value":4.36e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","score":0.8758000135421753},{"id":"502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","score":0.7168999910354614},{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.6506999731063843},{"id":"147897179","wikidata":"https://www.wikidata.org/wiki/Q407828","display_name":"Topoisomerase","score":0.6144000291824341},{"id":"98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","score":0.5099999904632568}],"counts_by_year":[{"year":2025,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2026,"works_count":21,"oa_works_count":17,"cited_by_count":1}],"display_name_alternatives":["Matthew Bonderud"],"block_key":"m bonderud","works_api_url":"https://api.openalex.org/works?filter=author.id:A5117230793","awards_count":0,"updated_date":"2026-11-01T11:00:13","created_date":"2025-04-21T00:00:00"}